Navigation Links
Diabetes Sufferers Offered Legal Help By Lancaster Firm
Date:8/29/2013

Lancaster, Pennsylvania (PRWEB) August 29, 2013

Lipitor, a statin used for the treatment of heart disease, quickly skyrocketed in popularity upon its introduction to the market. In fact, its widespread distribution helped it eclipse similar drugs like Zocor and Crestor to become the highest selling prescription drug of all time.

But recently, concerns have arisen that Lipitor (atorvastatin) could contribute to an increased susceptibility to diabetes. Studies have shown that women who take Lipitor are more likely to suffer from diabetes than if they were to use a placebo or even similar types of drugs (see link to the March 28, 2011, article from Reuters below).

Concerned about this threat, Handler Henning & Rosenberg is making their defective drug attorneys available to all those who believe their recent diabetes diagnosis was caused by Lipitor. The firm’s Lipitor injury lawyers believe that such parties may be entitled to legal representation upon filing a claim. W. Scott Henning details why the firm has chosen this moment to enter the fray:

“Every drug comes with certain side effects,” said Mr. Henning, “but these Lipitor-based diabetes diagnoses have become far too commonplace. When compared with other statins, the risk is simply unacceptable. Those who were misled by the claims of Lipitor deserve to have some recourse for the tough situation they’ve been put through.”

To help injured parties gain a better grasp of the situation, the firm has outlined some recent findings that allow for these lawsuits to move forward:

•Label Warnings- Even before the diabetes danger was disclosed, the Food and Drug Administration was forced to make revisions to the labels of Lipitor and other statins to reflect certain dangers. The side effects these warnings seek to relate include:

-Confusion
-Liver impairment
-Memory issues
-Muscle weakness derived from the onset of myopathy
-Heightened blood sugar

•A March 2011 study from the Journal of the American College of Cardiology outlined the potential diabetes risk that patients might face if they’re provided with Lipitor (a March 28, 2011 article from Reuters called “More evidence ties cholesterol drug, diabetes” relates those findings). By comparing low dose statins, high dose statins, and placebos, researchers were able to identify an increased risk of diabetes, especially when given to those persons whose medical history already left them at risk for the condition.

All things equal, persons provided with a placebo had a 6% chance of experiencing type 2 diabetes. With atorvastatin, that risk rose to 9%. Researchers then factored in high blood pressure and blood sugar, a high triglyceride count, and if the person was overweight, things that all increase the risk of diabetes. When a patient suffered from two of these risk factors, diabetes was 37% more likely with Lipitor. And almost half of those patients with all four factors who were provided with Lipitor suffered from diabetes.

•Another study from the BMJ journal featured in a Healthday story from May 24, 2013, titled “Could Statins Raise Diabetes Risk?” analyzed the health of 500,000 citizens of Ontario. That study revealed that the risk of diabetes was greater with Lipitor than even other statins. By using Pravachol as a baseline with which to compare (this statin carries a far lower risk of diabetes incursion), the study was able to deduce that those who take Lipitor were 22% more likely to develop diabetes. That’s higher than Crestor’s 18% greater likelihood and Zocor’s 10% higher chance when each was compared with Pravachol.

Given this information, it’s become clear to Handler Henning & Rosenberg that Lipitor users were exposed to a potentially dangerous product, especially if those persons already were at risk for diabetes. The law firm has launched a new web portal that invites all diabetes sufferers who believe their condition is due to Lipitor to contact the firm for a free consultation.

Handler Henning & Rosenberg has been assisting injured parties for more than 90 years. David H Rosenberg and the rest of the firm’s partners offer representation to those injured in a host of practice areas, including automobile accidents, defective medical devices, premises liability, dog bites, and more. Those injured by Lipitor may call to obtain a free consultation or drop by the HHR website to learn more about the firm’s services.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11058583.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Oregon Man Developed Bladder Cancer Brought on by Years of Ingesting Diabetes Drug Actos, Alleges Lawsuit Filed by Parker Waichman LLP
2. Univ. of Maryland research could result in new approach to prevent diabetes-induced birth defects
3. Byetta Lawsuit News: Bernstein Liebhard LLP Notes Establishment of Multidistrict Litigation For Federal Lawsuits Involving Byetta, Similar Diabetes Drugs
4. New NCES Diabetes Portion Plate Makes Portion Control Easy for People with Diabetes
5. Adapting to mainstream lowers diabetes risk in African-Americans
6. Thrive365 Launches New Era of Food Choices for People With Type 2 Diabetes
7. Gut taste mechanisms are abnormal in diabetes sufferers
8. Individuals with Diabetes May Experience Increased Risk of Disability, Allsup Explains
9. Longest and largest study of insulin pumps to treat type 1 diabetes in children shows they control blood sugar more effectively and with fewer complications than injections
10. Diet Doc Medically Supervised Diet Plans Reveals New Weight Loss Pills that Encourage Eating Clean, Wholesome Foods to Reduce the Risk for Diabetes
11. Florida Woman Developed Bladder Cancer After Taking Actos to Treat her Type II Diabetes, Alleges Lawsuit Filed by Parker Waichman LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: